Skip to main content
. 2014 Mar 4;(3):1–115. doi: 10.1002/14651858.CD006404.pub2

Analysis 5.1.

Analysis 5.1.

Comparison 5 Artesunate-pyronaridine versus artesunate-mefloquine; subgroup analysis, Outcome 1 Total failure PCR-adjusted (Day 28); subgrouped by region.